{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T04:30:47Z","timestamp":1783571447450,"version":"3.55.0"},"reference-count":143,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Cardiovasc Imaging"],"DOI":"10.1007\/s10554-022-02774-x","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T21:02:56Z","timestamp":1671656576000},"page":"793-809","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Role of cardiovascular magnetic resonance in the clinical evaluation of left ventricular hypertrophy: a 360\u00b0 panorama"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8812-2330","authenticated-orcid":false,"given":"Silvia","family":"Aguiar Rosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boban","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Pieroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccol\u00f2","family":"Maurizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Zampieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Cappelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Marchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Pradella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuno","family":"Cardim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Bogaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iacopo","family":"Olivotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,21]]},"reference":[{"issue":"5","key":"2774_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00003495-198800355-00002","volume":"35","author":"D Levy","year":"1988","unstructured":"Levy D (1988) Left ventricular hypertrophy: epidemiological insights from the Framingham heart study. Drugs 35(5):1\u20135","journal-title":"Drugs"},{"issue":"1","key":"2774_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/echo.12303","volume":"31","author":"AC Armstrong","year":"2014","unstructured":"Armstrong AC, Gjesdal O, Almeida A, Nacif M, Wu C, Bluemke DA, Brumback LLJ (2014) Left ventricular mass and hypertrophy by echocardiography and cardiac magnetic resonance: the multi-ethnic study of atherosclerosis. Echocardiography 31(1):12\u201320","journal-title":"Echocardiography"},{"issue":"25","key":"2774_CR3","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1016\/j.jacc.2008.09.014","volume":"52","author":"DA Bluemke","year":"2008","unstructured":"Bluemke DA, Kronmal RA, Lima JAC, Liu K, Olson J, Burke GL et al (2008) The relationship of left ventricular mass and geometry to incident cardiovascular events. The MESA (Multi-Ethnic Study of Atherosclerosis) study. J Am Coll Cardiol 52(25):2148\u20132155","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"2774_CR4","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.jcmg.2010.03.005","volume":"3","author":"S Gupta","year":"2010","unstructured":"Gupta S, Berry JD, Ayers CR, Peshock RM, Khera A, De Lemos JA et al (2010) Left ventricular hypertrophy, aortic wall thickness, and lifetime predicted risk of cardiovascular disease: the Dallas heart study. JACC Cardiovasc Imaging 3(6):605\u2013613","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"2774_CR5","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s10554-010-9584-5","volume":"26","author":"LC Brumback","year":"2010","unstructured":"Brumback LC, Kronmal R, Heckbert SR, Ni H, Hundley WG, Lima JA et al (2010) Body size adjustments for left ventricular mass by cardiovascular magnetic resonance and their impact on left ventricular hypertrophy classification. Int J Cardiovasc Imaging 26(4):459\u2013468","journal-title":"Int J Cardiovasc Imaging"},{"issue":"17","key":"2774_CR6","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1016\/j.jacc.2011.07.022","volume":"58","author":"WH Gaasch","year":"2011","unstructured":"Gaasch WH, Zile MR (2011) Left ventricular structural remodeling in health and disease: with special emphasis on volume, mass, and geometry. J Am Coll Cardiol 58(17):1733\u20131740","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"2774_CR7","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.jcmg.2016.08.011","volume":"10","author":"G Finocchiaro","year":"2017","unstructured":"Finocchiaro G, Dhutia H, D\u2019Silva A, Malhotra A, Steriotis A, Millar L et al (2017) Effect of sex and sporting discipline on LV adaptation to exercise. JACC Cardiovasc Imaging 10(9):965\u2013972","journal-title":"JACC Cardiovasc Imaging"},{"issue":"21","key":"2774_CR8","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1093\/eurheartj\/ehx532","volume":"39","author":"A Pelliccia","year":"2018","unstructured":"Pelliccia A, Caselli S, Sharma S, Basso C, Bax JJ, Corrado D et al (2018) European Association of Preventive Cardiology (EAPC) and European Association of Cardiovascular Imaging (EACVI) joint position statement: recommendations for the indication and interpretation of cardiovascular imaging in the evaluation of the athlete\u2019s he. Eur Heart J 39(21):1949\u20131969","journal-title":"Eur Heart J"},{"issue":"4","key":"2774_CR9","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.yjmcc.2011.08.028","volume":"52","author":"PG Camici","year":"2012","unstructured":"Camici PG, Olivotto I, Rimoldi OE (2012) The coronary circulation and blood flow in left ventricular hypertrophy. J Mol Cell Cardiol 52(4):857\u2013864","journal-title":"J Mol Cell Cardiol"},{"issue":"5","key":"2774_CR10","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.jacc.2005.10.050","volume":"47","author":"I Olivotto","year":"2006","unstructured":"Olivotto I, Cecchi F, Gistri R, Lorenzoni R, Chiriatti G, Girolami F et al (2006) Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy. J Am Coll Cardiol 47(5):1043\u20131048","journal-title":"J Am Coll Cardiol"},{"issue":"8P2","key":"2774_CR11","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1016\/j.jcmg.2018.03.020","volume":"12","author":"S Nordin","year":"2019","unstructured":"Nordin S, Kozor R, Medina-Menacho K, Abdel-Gadir A, Baig S, Sado DM et al (2019) Proposed stages of myocardial phenotype development in fabry disease. JACC Cardiovasc Imaging 12(8P2):1673\u20131683","journal-title":"JACC Cardiovasc Imaging"},{"key":"2774_CR12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ijcard.2016.06.311","volume":"221","author":"MB Stokes","year":"2016","unstructured":"Stokes MB, Taylor AJ, McLean CA, D\u2019Arcy CE, Mariani JA (2016) Severe left ventricular hypertrophy and marked cardiac fibrosis in Danon disease. Int J Cardiol 221:14\u201316","journal-title":"Int J Cardiol"},{"issue":"1","key":"2774_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12968-020-00607-1","volume":"22","author":"CM Kramer","year":"2020","unstructured":"Kramer CM, Barkhausen J, Bucciarelli-Ducci C, Flamm SD, Kim RJ, Nagel E (2020) Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update. J Cardiovasc Magn Reson 22(1):1\u201318","journal-title":"J Cardiovasc Magn Reson"},{"issue":"1","key":"2774_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0002-9149(02)02381-0","volume":"90","author":"F Grothues","year":"2002","unstructured":"Grothues F, Smith GC, Moon JCC, Bellenger NG, Collins P, Klein HU et al (2002) Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 90(1):29\u201334","journal-title":"Am J Cardiol"},{"issue":"1","key":"2774_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12968-020-00683-3","volume":"22","author":"N Kawel-Boehm","year":"2020","unstructured":"Kawel-Boehm N, Hetzel SJ, Ambale-Venkatesh B, Captur G, Francois CJ, Jerosch-Herold M et al (2020) Reference ranges (\u201cnormal values\u201d) for cardiovascular magnetic resonance (CMR) in adults and children: 2020 update. J Cardiovasc Magn Reson 22(1):1\u201363","journal-title":"J Cardiovasc Magn Reson"},{"issue":"12","key":"2774_CR16","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1093\/ehjci\/jez232","volume":"20","author":"SE Petersen","year":"2019","unstructured":"Petersen SE, Khanji MY, Plein S, Lancellotti P, Bucciarelli-Ducci C (2019) European Association of Cardiovascular Imaging expert consensus paper: a comprehensive review of cardiovascular magnetic resonance normal values of cardiac chamber size and aortic root in adults and recommendations for grading severity. Eur Heart J Cardiovasc Imaging 20(12):1321\u20131331","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"1","key":"2774_CR17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12968-017-0389-8","volume":"19","author":"DR Messroghli","year":"2017","unstructured":"Messroghli DR, Moon JC, Ferreira VM, Grosse-Wortmann L, He T, Kellman P et al (2017) Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2 and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imagin. J Cardiovasc Magn Reson 19(1):75","journal-title":"J Cardiovasc Magn Reson"},{"issue":"11 Pt 2","key":"2774_CR18","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1016\/j.jcmg.2019.05.033","volume":"12","author":"BP Halliday","year":"2019","unstructured":"Halliday BP, Prasad SK (2019) The interstitium in the hypertrophied heart. JACC Cardiovasc Imaging 12(11 Pt 2):2357\u20132368","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"2774_CR19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jcmg.2017.04.006","volume":"11","author":"S Nakamori","year":"2018","unstructured":"Nakamori S, Dohi K, Ishida M, Goto Y, Imanaka-Yoshida K, Omori T et al (2018) Native T1 mapping and extracellular volume mapping for the assessment of diffuse myocardial fibrosis in dilated cardiomyopathy. JACC Cardiovasc Imaging 11(1):48\u201359","journal-title":"JACC Cardiovasc Imaging"},{"issue":"11P2","key":"2774_CR20","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1016\/j.jcmg.2019.06.031","volume":"12","author":"AA Robinson","year":"2019","unstructured":"Robinson AA, Chow K, Salerno M (2019) Myocardial T1 and ECV measurement: underlying concepts and technical considerations. JACC Cardiovasc Imaging 12(11P2):2332\u20132344","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"2774_CR21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/ehjci\/jeu182","volume":"16","author":"LM Iles","year":"2015","unstructured":"Iles LM, Ellims AH, Llewellyn H, Hare JL, Kaye DM, McLean CA et al (2015) Histological validation of cardiac magnetic resonance analysis of regional and diffuse interstitial myocardial fibrosis. Eur Heart J Cardiovasc Imaging 16(1):14\u201322","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"12","key":"2774_CR22","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1016\/j.jacc.2004.03.035","volume":"43","author":"JCC Moon","year":"2004","unstructured":"Moon JCC, Reed E, Sheppard MN, Elkington AG, Ho SY, Burke M et al (2004) The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 43(12):2260\u20132264","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"2774_CR23","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/j.amjcard.2014.07.070","volume":"114","author":"S Caselli","year":"2014","unstructured":"Caselli S, Maron MS, Urbano-Moral JA, Pandian NG, Maron BJ, Pelliccia A (2014) Differentiating left ventricular hypertrophy in athletes from that in patients with hypertrophic cardiomyopathy. Am J Cardiol 114(9):1383\u20131389","journal-title":"Am J Cardiol"},{"issue":"11","key":"2774_CR24","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.tibs.2004.09.002","volume":"29","author":"T Wakatsuki","year":"2004","unstructured":"Wakatsuki T, Schlessinger J, Elson EL (2004) The biochemical response of the heart to hypertension and exercise. Trends Biochem Sci 29(11):609\u2013617","journal-title":"Trends Biochem Sci"},{"key":"2774_CR25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ejrad.2019.06.001","volume":"117","author":"\u0141A Ma\u0142ek","year":"2019","unstructured":"Ma\u0142ek \u0141A, Barczuk-Fal\u0119cka M, Werys K, Czajkowska A, Mr\u00f3z A, Witek K et al (2019) Cardiovascular magnetic resonance with parametric mapping in long-term ultra-marathon runners. Eur J Radiol 117:89\u201394","journal-title":"Eur J Radiol"},{"issue":"4","key":"2774_CR26","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.115.003579","volume":"9","author":"AK McDiarmid","year":"2016","unstructured":"McDiarmid AK, Swoboda PP, Erhayiem B, Lancaster RE, Lyall GK, Broadbent DA et al (2016) Athletic cardiac adaptation in males is a consequence of elevated myocyte mass. Circ Cardiovasc Imaging 9(4):e003579","journal-title":"Circ Cardiovasc Imaging"},{"issue":"8","key":"2774_CR27","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1161\/hc0802.104534","volume":"105","author":"A Pelliccia","year":"2002","unstructured":"Pelliccia A, Maron BJ, De Luca R, Di Paolo FM, Spataro A, Culasso F (2002) Remodeling of left ventricular hypertrophy in elite athletes after long-term deconditioning. Circulation 105(8):944\u2013949","journal-title":"Circulation"},{"key":"2774_CR28","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.3313","author":"ET Ha","year":"2018","unstructured":"Ha ET, Weinrauch ML, Brensilver J (2018) Non-ischemic cardiomyopathy secondary to left ventricular hypertrophy due to long-term anabolic-androgenic steroid use in a former olympic athlete. Cureus. https:\/\/doi.org\/10.7759\/cureus.3313","journal-title":"Cureus"},{"issue":"5","key":"2774_CR29","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1136\/hrt.2003.015719","volume":"90","author":"A Urhausen","year":"2004","unstructured":"Urhausen A, Albers T, Kindermann W (2004) Are the cardiac effects of anabolic steroid abuse in strength athletes reversible? Heart 90(5):496\u2013501","journal-title":"Heart"},{"issue":"8","key":"2774_CR30","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1002\/clc.23360","volume":"43","author":"\u0141A Ma\u0142ek","year":"2020","unstructured":"Ma\u0142ek \u0141A, Bucciarelli-Ducci C (2020) Myocardial fibrosis in athletes: current perspective. Clin Cardiol 43(8):882\u2013888","journal-title":"Clin Cardiol"},{"issue":"5","key":"2774_CR31","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1161\/HYPERTENSIONAHA.106.079426","volume":"49","author":"GW Dorn","year":"2007","unstructured":"Dorn GW (2007) The fuzzy logic of physiological cardiac hypertrophy. Hypertension 49(5):962\u2013970","journal-title":"Hypertension"},{"issue":"2","key":"2774_CR32","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ijcard.2007.01.089","volume":"124","author":"DF D\u00e1vila","year":"2008","unstructured":"D\u00e1vila DF, Donis JH, Odreman R, Gonzalez M, Landaeta A (2008) Patterns of left ventricular hypertrophy in essential hypertension: should echocardiography guide the pharmacological treatment? Int J Cardiol 124(2):134\u2013138","journal-title":"Int J Cardiol"},{"issue":"2","key":"2774_CR33","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jcmg.2014.09.020","volume":"8","author":"S Kuruvilla","year":"2015","unstructured":"Kuruvilla S, Janardhanan R, Antkowiak P, Keeley EC, Adenaw N, Brooks J et al (2015) Increased extracellular volume and altered mechanics are associated with LVH in hypertensive heart disease, not hypertension alone. JACC Cardiovasc Imaging 8(2):172\u2013180","journal-title":"JACC Cardiovasc Imaging"},{"issue":"14","key":"2774_CR34","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1161\/01.CIR.101.14.1729","volume":"101","author":"R Querejeta","year":"2000","unstructured":"Querejeta R, Varo N, L\u00f3pez B, Larman M, Arti\u00f1ano E, Etayo JC et al (2000) Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease. Circulation 101(14):1729\u20131735","journal-title":"Circulation"},{"issue":"4","key":"2774_CR35","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/ncpcardio0158","volume":"2","author":"J D\u00edez","year":"2005","unstructured":"D\u00edez J, Gonz\u00e1lez A, L\u00f3pez B, Querejeta R (2005) Mechanisms of disease: pathologic structural remodeling is more than adaptive hypertrophy in hypertensive heart disease. Nat Clin Pract Cardiovasc Med 2(4):209\u2013216","journal-title":"Nat Clin Pract Cardiovasc Med"},{"issue":"1","key":"2774_CR36","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12968-015-0176-3","volume":"17","author":"TA Treibel","year":"2015","unstructured":"Treibel TA, Zemrak F, Sado DM, Banypersad SM, White SK, Maestrini V et al (2015) Extracellular volume quantification in isolated hypertension - changes at the detectable limits? J Cardiovasc Magn Reson 17(1):74","journal-title":"J Cardiovasc Magn Reson"},{"issue":"11","key":"2774_CR37","doi-asserted-by":"publisher","first-page":"4620","DOI":"10.1007\/s00330-017-4841-9","volume":"27","author":"S Wang","year":"2017","unstructured":"Wang S, Hu H, Lu M, Sirajuddin A, Li J, An J et al (2017) Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in hypertension and associated with left ventricular remodeling. Eur Radiol 27(11):4620\u20134630","journal-title":"Eur Radiol"},{"issue":"8","key":"2774_CR38","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1007\/s10554-014-0487-8","volume":"30","author":"J Kim","year":"2014","unstructured":"Kim J, Kochav JD, Gurevich S, Afroz A, Petashnick M, Volo S et al (2014) Left ventricular geometric remodeling in relation to non-ischemic scar pattern on cardiac magnetic resonance imaging. Int J Cardiovasc Imaging 30(8):1559\u20131567","journal-title":"Int J Cardiovasc Imaging"},{"issue":"3","key":"2774_CR39","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jacc.2008.08.064","volume":"53","author":"A Rudolph","year":"2009","unstructured":"Rudolph A, Abdel-Aty H, Bohl S, Boy\u00e9 P, Zagrosek A, Dietz R et al (2009) Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy. Relation to remodeling. J Am Coll Cardiol 53(3):284\u2013291","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"2774_CR40","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1097\/00004872-200207000-00032","volume":"20","author":"ML Muiesan","year":"2002","unstructured":"Muiesan ML, Rizzoni D, Salvetti M, Porteri E, Monteduro C, Guelfi D et al (2002) Structural changes in small resistance arteries and left ventricular geometry in patients with primary and secondary hypertension. J Hypertens 20(7):1439\u20131444","journal-title":"J Hypertens"},{"issue":"33","key":"2774_CR41","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1093\/eurheartj\/ehu093","volume":"35","author":"F Mahfoud","year":"2014","unstructured":"Mahfoud F, Urban D, Teller D, Linz D, Stawowy P, Hassel JH et al (2014) Effect of renal denervation on left ventricular mass and function in patients with resistant hypertension: data from a multi-centre cardiovascular magnetic resonance imaging trial. Eur Heart J 35(33):2224\u20132231","journal-title":"Eur Heart J"},{"issue":"19","key":"2774_CR42","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1093\/eurheartj\/eht534","volume":"35","author":"SF Rimoldi","year":"2014","unstructured":"Rimoldi SF, Scherrer U, Messerli FH (2014) Secondary arterial hypertension: when, who, and how to screen? Eur Heart J 35(19):1245\u20131254","journal-title":"Eur Heart J"},{"issue":"6","key":"2774_CR43","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1161\/01.CIR.95.6.1471","volume":"95","author":"GP Rossi","year":"1997","unstructured":"Rossi GP, Sacchetto A, Pavan E, Palatini P, Graniero GR, Canali C et al (1997) Remodeling of the left ventricle in primary aldosteronism due to conn\u2019s adenoma. Circulation 95(6):1471\u20131478","journal-title":"Circulation"},{"issue":"6","key":"2774_CR44","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1161\/CIRCIMAGING.112.974576","volume":"5","author":"EM Freel","year":"2012","unstructured":"Freel EM, Mark PB, Weir RAP, McQuarrie EP, Allan K, Dargie HJ et al (2012) Demonstration of blood pressure-independent noninfarct myocardial fibrosis in primary aldosteronism: a cardiac magnetic resonance imaging study. Circ Cardiovasc Imaging 5(6):740\u2013747","journal-title":"Circ Cardiovasc Imaging"},{"issue":"6","key":"2774_CR45","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1002\/jmri.23592","volume":"35","author":"MYM Su","year":"2012","unstructured":"Su MYM, Wu VC, Yu HY, Lin YH, Kuo CC, Liu KL et al (2012) Contrast-enhanced MRI index of diffuse myocardial fibrosis is increased in primary aldosteronism. J Magn Reson Imaging 35(6):1349\u20131355","journal-title":"J Magn Reson Imaging"},{"issue":"11","key":"2774_CR46","doi-asserted-by":"publisher","first-page":"E2144","DOI":"10.1210\/jc.2014-1783","volume":"99","author":"P Kamenick\u00fd","year":"2014","unstructured":"Kamenick\u00fd P, Redheuil A, Roux C, Salenave S, Kachenoura N, Raissouni Z et al (2014) Cardiac structure and function in cushing\u2019s syndrome: a cardiac magnetic resonance imaging study. J Clin Endocrinol Metab 99(11):E2144\u2013E2153","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2774_CR47","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1530\/EJE-11-0601","volume":"166","author":"KH Yiu","year":"2012","unstructured":"Yiu KH, Marsan NA, Delgado V, Biermasz NR, Holman ER, Smit JWA et al (2012) Increased myocardial fibrosis and left ventricular dysfunction in Cushing\u2019s syndrome. Eur J Endocrinol 166(1):27\u201334","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2774_CR48","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1530\/EJE-07-0455","volume":"157","author":"BR Walker","year":"2007","unstructured":"Walker BR (2007) Glucocorticoids and cardiovascular disease. Eur J Endocrinol 157(5):545\u2013559","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2774_CR49","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/jmri.25374","volume":"45","author":"C Roux","year":"2017","unstructured":"Roux C, Kachenoura N, Raissuni Z, Mousseaux E, Young J, Graves MJ et al (2017) Effects of cortisol on the heart: characterization of myocardial involvement in cushing\u2019s disease by longitudinal cardiac MRI T1 mapping. J Magn Reson Imaging 45(1):147\u2013156","journal-title":"J Magn Reson Imaging"},{"issue":"20","key":"2774_CR50","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1016\/j.jacc.2016.03.543","volume":"67","author":"VM Ferreira","year":"2016","unstructured":"Ferreira VM, Marcelino M, Piechnik SK, Marini C, Karamitsos TD, Ntusi NAB et al (2016) Pheochromocytoma is characterized by catecholamine-mediated myocarditis, focal and diffuse myocardial fibrosis, and myocardial dysfunction. J Am Coll Cardiol 67(20):2364\u20132374","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"2774_CR51","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.jash.2012.04.002","volume":"6","author":"M Iida","year":"2012","unstructured":"Iida M, Yamamoto M, Ishiguro Y, Yamazaki M, Honjo H, Kamiya K (2012) Thyroid hormone within the normal range is associated with left ventricular mass in patients with hypertension. J Am Soc Hypertens 6(4):261\u2013269","journal-title":"J Am Soc Hypertens"},{"issue":"2","key":"2774_CR52","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1210\/jc.2004-1554","volume":"90","author":"M D\u00f6rr","year":"2005","unstructured":"D\u00f6rr M, Wolff B, Robinson DM, John U, L\u00fcdemann J, Meng W et al (2005) The association of thyroid function with cardiac mass and left ventricular hypertrophy. J Clin Endocrinol Metab 90(2):673\u2013677","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2774_CR53","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1172\/JCI114737","volume":"86","author":"J Timsit","year":"1990","unstructured":"Timsit J, Riou B, Bertherat J, Wisnewsky C, Kato NS, Weisberg AS et al (1990) Effects of chronic growth hormone hypersecretion on intrinsic contractility, energetics, isomyosin pattern, and myosin adenosine triphosphatase activity of rat left ventricle. J Clin Invest 86(2):507\u2013515","journal-title":"J Clin Invest"},{"issue":"3","key":"2774_CR54","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/clc.22867","volume":"41","author":"AN Sharma","year":"2018","unstructured":"Sharma AN, Tan M, Amsterdam EA, Singh GD (2018) Acromegalic cardiomyopathy: epidemiology, diagnosis, and management. Clin Cardiol 41(3):419\u2013425","journal-title":"Clin Cardiol"},{"key":"2774_CR55","doi-asserted-by":"publisher","first-page":"2018464","DOI":"10.1155\/2020\/2018464","volume":"2020","author":"X Guo","year":"2020","unstructured":"Guo X, Cao J, Liu P, Cao Y, Li X, Gao L et al (2020) Cardiac abnormalities in acromegaly patients: a cardiac magnetic resonance study. Int J Endocrinol 2020:2018464","journal-title":"Int J Endocrinol"},{"issue":"3","key":"2774_CR56","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1365-2265.2007.03047.x","volume":"68","author":"F Bogazzi","year":"2008","unstructured":"Bogazzi F, Lombardi M, Strata E, Aquaro G, Di Bello V, Cosci C et al (2008) High prevalence of cardiac hypertophy without detectable signs of fibrosis in patients with untreated active acromegaly: an in vivo study using magnetic resonance imaging. Clin Endocrinol (Oxf) 68(3):361\u2013368","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2774_CR57","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.2214\/AJR.07.2031","volume":"190","author":"H Gouya","year":"2008","unstructured":"Gouya H, Vignaux O, Le Roux P, Chanson P, Bertherat J, Bertagna X et al (2008) Rapidly reversible myocardial edema in patients with acromegaly: assessment with ultrafast T2 mapping in a single-breath-hold MRI sequence. Am J Roentgenol 190(6):1576\u20131582","journal-title":"Am J Roentgenol"},{"key":"2774_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.598948","volume":"11","author":"X Guo","year":"2020","unstructured":"Guo X, Cao Y, Cao J, Li X, Liu P, Wang Z et al (2020) Reversibility of cardiac involvement in acromegaly patients after surgery: 12-month follow-up using cardiovascular magnetic resonance. Front Endocrinol (Lausanne) 11:598948","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"2774_CR59","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1164\/ajrccm.163.7.2007014","volume":"163","author":"M Niroumand","year":"2001","unstructured":"Niroumand M, Kuperstein R, Sasson Z, Hanly PJ (2001) Impact of obstructive sleep apnea on left ventricular mass and diastolic function. Am J Respir Crit Care Med 163(7):1632\u20131636","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"2774_CR60","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/j.1524-6175.2004.02868.x","volume":"6","author":"LM Prisant","year":"2004","unstructured":"Prisant LM, Mawulawde K, Kapoor D, Joe C (2004) Coarctation of the aorta: a secondary cause of hypertension. J Clin Hypertens (Greenwich) 6(6):347\u2013350","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"5","key":"2774_CR61","doi-asserted-by":"publisher","first-page":"5029","DOI":"10.1016\/j.ijcard.2013.07.158","volume":"168","author":"P Luijendijk","year":"2013","unstructured":"Luijendijk P, Bouma BJ, Vriend JWJ, Groenink M, Spijkerboer AM, Mulder BJM (2013) Left ventricular fibrosis in adults after coarctation repair, does it play a role? Int J Cardiol 168(5):5029\u20135030","journal-title":"Int J Cardiol"},{"issue":"1","key":"2774_CR62","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/clc.22775","volume":"41","author":"SR Devabhaktuni","year":"2018","unstructured":"Devabhaktuni SR, Chakfeh E, Malik AO, Pengson JA, Rana J, Ahsan CH (2018) Subvalvular aortic stenosis: a review of current literature. Clin Cardiol 41(1):131\u2013136","journal-title":"Clin Cardiol"},{"issue":"6","key":"2774_CR63","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1161\/CIRCGENETICS.112.962860","volume":"5","author":"G Merla","year":"2012","unstructured":"Merla G, Brunetti-Pierri N, Piccolo P, Micale L, Loviglio MN (2012) Supravalvular aortic stenosis: elastin arteriopathy. Circ Cardiovasc Genet 5(6):692\u2013696","journal-title":"Circ Cardiovasc Genet"},{"issue":"8","key":"2774_CR64","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1056\/NEJMra061889","volume":"356","author":"PGCF Camici","year":"2007","unstructured":"Camici PGCF (2007) Coronary microvascular dysfunction. N Engl J Med 356(8):830\u2013840","journal-title":"N Engl J Med"},{"issue":"1","key":"2774_CR65","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1093\/oxfordjournals.eurheartj.a015090","volume":"18","author":"L Choudhury","year":"1997","unstructured":"Choudhury L, Rosen SD, Patel D, Nihoyannopoulos P, Camici PG (1997) Coronary vasodilator reserve in primary and secondary left ventricular hypertrophy. A study with positron emission tomography. Eur Heart J 18(1):108\u2013116","journal-title":"Eur Heart J"},{"issue":"7","key":"2774_CR66","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1161\/01.CIR.0000051865.66123.B7","volume":"107","author":"S Hein","year":"2003","unstructured":"Hein S, Arnon E, Kostin S, Sch\u00f6nburg M, Els\u00e4sser A, Polyakova V et al (2003) Progression from compensated hypertrophy to failure in the pressure-overloaded human: heart structural deterioration and compensatory mechanisms. Circulation 107(7):984\u2013991","journal-title":"Circulation"},{"issue":"7","key":"2774_CR67","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.jcmg.2017.08.025","volume":"11","author":"TA Treibel","year":"2018","unstructured":"Treibel TA, Kozor R, Fontana M, Torlasco C, Reant P, Badiani S et al (2018) Sex dimorphism in the myocardial response to aortic stenosis. JACC Cardiovasc Imaging 11(7):962\u2013973","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"2774_CR68","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1148\/radiol.14141120","volume":"274","author":"SP Lee","year":"2015","unstructured":"Lee SP, Lee W, Lee JM, Park EA, Kim HK, Kim YJ et al (2015) Assessment of diffuse myocardial fibrosis by using MR imaging in asymptomatic patients with aortic stenosis. Radiology 274(2):359\u2013369","journal-title":"Radiology"},{"issue":"3","key":"2774_CR69","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1148\/radiol.2016141802","volume":"278","author":"EB Schelbert","year":"2016","unstructured":"Schelbert EB, Messroghli DR (2016) State of the art: clinical applications of cardiac T1 mapping. Radiology 278(3):658\u2013676","journal-title":"Radiology"},{"issue":"3","key":"2774_CR70","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.jacc.2019.11.032","volume":"75","author":"RJ Everett","year":"2020","unstructured":"Everett RJ, Treibel TA, Fukui M, Lee H, Rigolli M, Singh A et al (2020) Extracellular myocardial volume in patients with aortic stenosis. J Am Coll Cardiol 75(3):304\u2013316","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"2774_CR71","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1136\/hrt.2005.079392","volume":"92","author":"K Debl","year":"2006","unstructured":"Debl K, Djavidani B, Buchner S, Lipke C, Nitz W, Feuerbach S et al (2006) Delayed hyperenhancement in magnetic resonance imaging of left ventricular hypertrophy caused by aortic stenosis and hypertrophic cardiomyopathy: visualisation of focal fibrosis. Heart 92(10):1447\u20131451","journal-title":"Heart"},{"issue":"12","key":"2774_CR72","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.jacc.2011.03.064","volume":"58","author":"MR Dweck","year":"2011","unstructured":"Dweck MR, Joshi S, Murigu T, Alpendurada F, Jabbour A, Melina G et al (2011) Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis. J Am Coll Cardiol 58(12):1271\u20131279","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"2774_CR73","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1161\/CIRCULATIONAHA.108.847772","volume":"120","author":"F Weidemann","year":"2009","unstructured":"Weidemann F, Herrmann S, St\u00f6rk S, Niemann M, Frantz S, Lange V et al (2009) Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis. Circulation 120(7):577\u2013584","journal-title":"Circulation"},{"issue":"4","key":"2774_CR74","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1161\/01.CIR.79.4.744","volume":"79","author":"HP Krayenbuehl","year":"1989","unstructured":"Krayenbuehl HP, Hess OM, Monrad ES, Schneider J, Mall G, Turina M (1989) Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement. Circulation 79(4):744\u2013755","journal-title":"Circulation"},{"issue":"8","key":"2774_CR75","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.jacc.2017.12.035","volume":"71","author":"TA Treibel","year":"2018","unstructured":"Treibel TA, Kozor R, Schofield R, Benedetti G, Fontana M, Bhuva AN et al (2018) Reverse myocardial remodeling following valve replacement in patients with aortic stenosis. J Am Coll Cardiol 71(8):860\u2013871","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"2774_CR76","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jacc.2020.11.006","volume":"77","author":"C Nitsche","year":"2021","unstructured":"Nitsche C, Scully PR, Patel KP, Kammerlander AA, Koschutnik M, Dona C et al (2021) Prevalence and outcomes of concomitant aortic stenosis and cardiac amyloidosis. J Am Coll Cardiol 77(2):128\u2013139","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"2774_CR77","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1016\/j.jacc.2019.09.056","volume":"74","author":"J Ternacle","year":"2019","unstructured":"Ternacle J, Krapf L, Mothy D, Magne J, Nguyen A, Galat A et al (2019) Aortic stenosis and cardiac amyloidosis: JACC review topic of the week. J Am Coll Cardiol 74(21):2638\u20132651","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2774_CR78","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12968-017-0415-x","volume":"19","author":"JL Cavalcante","year":"2017","unstructured":"Cavalcante JL, Rijal S, Abdelkarim I, Althouse AD, Sharbaugh MS, Fridman Y et al (2017) Cardiac amyloidosis is prevalent in older patients with aortic stenosis and carries worse prognosis. J Cardiovasc Magn Reson 19(1):98","journal-title":"J Cardiovasc Magn Reson"},{"issue":"1","key":"2774_CR79","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jcmg.2019.03.026","volume":"13","author":"A Baggiano","year":"2020","unstructured":"Baggiano A, Boldrini M, Martinez-Naharro A, Kotecha T, Petrie A, Rezk T et al (2020) Noncontrast magnetic resonance for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging 13(1):69\u201380","journal-title":"JACC Cardiovasc Imaging"},{"issue":"25","key":"2774_CR80","first-page":"e533","volume":"142","author":"SR Ommen","year":"2020","unstructured":"Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P et al (2020) 2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 142(25):e533\u2013e557","journal-title":"J Am Coll Cardiol"},{"issue":"39","key":"2774_CR81","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","volume":"35","author":"PM Elliott","year":"2014","unstructured":"Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, Hagege AA, Lafont A, Limongelli G, Mahrholdt H, McKenna WJ, Mogensen J, Nihoyannopoulos P, Nistri S, Pieper PG, Pieske B, Rapezzi C, Rutten FH, Tillmanns CWH (2014) 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 35(39):2733\u20132779","journal-title":"Eur Heart J"},{"issue":"6","key":"2774_CR82","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.mayocp.2014.01.025","volume":"89","author":"JM Bos","year":"2014","unstructured":"Bos JM, Will ML, Gersh BJ, Kruisselbrink TM, Ommen SR, Ackerman MJ (2014) Characterization of a phenotype-based genetic test prediction score for unrelated patients with hypertrophic cardiomyopathy. Mayo Clin Proc 89(6):727\u2013737. https:\/\/doi.org\/10.1016\/j.mayocp.2014.01.025","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"2774_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12872-021-01927-5","volume":"21","author":"J Hathaway","year":"2021","unstructured":"Hathaway J, Heli\u00f6 K, Saarinen I, Tallila J, Sepp\u00e4l\u00e4 EH, Tuupanen S et al (2021) Diagnostic yield of genetic testing in a heterogeneous cohort of 1376 HCM patients. BMC Cardiovasc Disord 21(1):1\u201311. https:\/\/doi.org\/10.1186\/s12872-021-01927-5","journal-title":"BMC Cardiovasc Disord"},{"issue":"3","key":"2774_CR84","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jacc.2009.05.006","volume":"54","author":"MS Maron","year":"2009","unstructured":"Maron MS, Maron BJ, Harrigan C, Buros J, Gibson CM, Olivotto I et al (2009) Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. J Am Coll Cardiol 54(3):220\u2013228","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"2774_CR85","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/heart.84.5.476","volume":"84","author":"AM Varnava","year":"2000","unstructured":"Varnava AM, Elliott PM, Sharma S, McKenna WJ, Davies MJ (2000) Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis and small vessel disease. Heart 84(5):476\u2013482","journal-title":"Heart"},{"issue":"8","key":"2774_CR86","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1053\/hupa.2000.16659","volume":"31","author":"C Basso","year":"2000","unstructured":"Basso C, Thiene G, Corrado D, Buja G, Melacini P, Nava A (2000) Hypertrophic cardiomyopathy and sudden death in the young: Pathologic evidence of myocardial ischemia. Hum Pathol 31(8):988\u2013998","journal-title":"Hum Pathol"},{"issue":"3","key":"2774_CR87","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S0735-1097(86)80181-4","volume":"8","author":"BJ Maron","year":"1986","unstructured":"Maron BJ, Wolfson JK, Epstein SE, Roberts WC (1986) Intramural (\u201csmall vessel\u201d) coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol 8(3):545\u2013557","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2774_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12968-014-0049-1","volume":"16","author":"TF Ismail","year":"2014","unstructured":"Ismail TF, Hsu L-Y, Greve AM, Gon\u00e7alves C, Jabbour A, Gulati A et al (2014) Coronary microvascular ischemia in hypertrophic cardiomyopathy - a pixel-wise quantitative cardiovascular magnetic resonance perfusion study. J Cardiovasc Magn Reson 16(1):1\u201310","journal-title":"J Cardiovasc Magn Reson"},{"key":"2774_CR89","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12968-016-0223-8","volume":"18","author":"ADM Villa","year":"2016","unstructured":"Villa ADM, Sammut E, Zarinabad N, Carr-White G, Lee J, Bettencourt N et al (2016) Microvascular ischemia in hypertrophic cardiomyopathy: new insights from high-resolution combined quantification of perfusion and late gadolinium enhancement. J Cardiovasc Magn Reson 18:4","journal-title":"J Cardiovasc Magn Reson"},{"issue":"18","key":"2774_CR90","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1161\/CIRCULATIONAHA.106.657023","volume":"115","author":"SE Petersen","year":"2007","unstructured":"Petersen SE, Jerosch-Herold M, Hudsmith LE, Robson MD, Francis JM, Doll HA et al (2007) Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging. Circulation 115(18):2418\u20132425","journal-title":"Circulation"},{"key":"2774_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcvm.2021.761860","volume":"8","author":"S Aguiar Rosa","year":"2021","unstructured":"Aguiar Rosa S, Thomas B, Fiarresga A, Papoila AL, Alves M, Pereira R et al (2021) The impact of ischemia assessed by magnetic resonance on functional, arrhythmic, and imaging features of hypertrophic cardiomyopathy. Front Cardiovasc Med 8:1\u201311","journal-title":"Front Cardiovasc Med"},{"key":"2774_CR92","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.116.003090","author":"G Galati","year":"2016","unstructured":"Galati G, Leone O, Pasquale F, Olivotto I, Biagini E, Grigioni F et al (2016) Histological and histometric characterization of myocardial fibrosis in end-stage hypertrophic cardiomyopathy. Circ Heart Fail. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.116.003090","journal-title":"Circ Heart Fail"},{"issue":"1","key":"2774_CR93","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S0735-1097(99)00492-1","volume":"35","author":"J Shirani","year":"2000","unstructured":"Shirani J, Pick R, Roberts WC, Maron BJ (2000) Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. J Am Coll Cardiol 35(1):36\u201344","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"2774_CR94","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1161\/CIRCIMAGING.112.000333","volume":"6","author":"CY Ho","year":"2013","unstructured":"Ho CY, Abbasi SA, Neilan TG, Shah RV, Chen Y, Heydari B et al (2013) T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy. Circ Cardiovasc Imaging 6(3):415\u2013422","journal-title":"Circ Cardiovasc Imaging"},{"issue":"10","key":"2774_CR95","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1093\/ehjci\/jeu077","volume":"15","author":"AH Ellims","year":"2014","unstructured":"Ellims AH, Iles LM, Ling LH, Chong B, Macciocca I, Slavin GS et al (2014) A comprehensive evaluation of myocardial fibrosis in hypertrophic cardio myopathy with cardiacmagnetic resonance imaging: linking genotype with fibrotic phenotype. Eur Heart J Cardiovasc Imaging 15(10):1108\u20131116","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"6","key":"2774_CR96","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.113.007094","volume":"130","author":"RH Chan","year":"2014","unstructured":"Chan RH, Maron BJ, Olivotto I, Pencina MJ, Assenza GE, Haas T et al (2014) Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy. Circulation 130(6):484\u2013495","journal-title":"Circulation"},{"issue":"10","key":"2774_CR97","doi-asserted-by":"publisher","first-page":"e111366","DOI":"10.1371\/journal.pone.0111366","volume":"9","author":"G Todiere","year":"2014","unstructured":"Todiere G, Pisciella L, Barison A, Del Franco A, Zachara E, Piaggi P et al (2014) Abnormal T2-STIR magnetic resonance in hypertrophic cardiomyopathy: a marker of advanced disease and electrical myocardial instability. PLoS ONE 9(10):e111366","journal-title":"PLoS ONE"},{"issue":"20","key":"2774_CR98","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1016\/j.jacc.2019.02.065","volume":"73","author":"R Ariga","year":"2019","unstructured":"Ariga R, Tunnicliffe EM, Manohar SG, Mahmod M, Raman B, Piechnik SK et al (2019) Identification of myocardial disarray in patients with hypertrophic cardiomyopathy and ventricular arrhythmias. J Am Coll Cardiol 73(20):2493\u20132502","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2774_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12968-014-0087-8","volume":"16","author":"PF Ferreira","year":"2014","unstructured":"Ferreira PF, Kilner PJ, Mcgill LA, Nielles-Vallespin S, Scott AD, Ho SY et al (2014) In vivo cardiovascular magnetic resonance diffusion tensor imaging shows evidence of abnormal myocardial laminar orientations and mobility in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson 16(1):1\u201316","journal-title":"J Cardiovasc Magn Reson"},{"issue":"6","key":"2774_CR100","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/ehjci\/jex323","volume":"19","author":"G Quarta","year":"2018","unstructured":"Quarta G, Aquaro GD, Pedrotti P, Pontone G, Dellegrottaglie S, Iacovoni A et al (2018) Cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy: the importance of clinical context. Eur Heart J Cardiovasc Imaging 19(6):601\u2013610","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"1","key":"2774_CR101","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12968-015-0114-4","volume":"17","author":"R Kozor","year":"2015","unstructured":"Kozor R, Callaghan F, Tchan M, Hamilton-Craig C, Figtree GA, Grieve SM (2015) A disproportionate contribution of papillary muscles and trabeculations to total left ventricular mass makes choice of cardiovascular magnetic resonance analysis technique critical in Fabry disease. J Cardiovasc Magn Reson 17(1):22","journal-title":"J Cardiovasc Magn Reson"},{"issue":"1","key":"2774_CR102","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ultrasmedbio.2010.10.017","volume":"37","author":"M Niemann","year":"2011","unstructured":"Niemann M, Liu D, Hu K, Herrmann S, Breunig F, Strotmann J et al (2011) Prominent papillary muscles in fabry disease: a diagnostic marker? Ultrasound Med Biol 37(1):37\u201343","journal-title":"Ultrasound Med Biol"},{"issue":"1","key":"2774_CR103","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/eurheartj\/ehp387","volume":"31","author":"N Brakch","year":"2010","unstructured":"Brakch N, Dormond O, Bekri S, Golshayan D, Correvon M, Mazzolai L et al (2010) Evidence for a role of sphingosine-1 phosphate in cardiovascular remodelling in Fabry disease. Eur Heart J 31(1):67\u201376","journal-title":"Eur Heart J"},{"issue":"4","key":"2774_CR104","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1161\/01.ATV.0000209649.60409.38","volume":"26","author":"F Barbey","year":"2006","unstructured":"Barbey F, Brakch N, Linhart A, Rosenblatt-Velin N, Jeanrenaud X, Qanadli S et al (2006) Cardiac and vascular hypertrophy in Fabry disease: evidence for a new mechanism independent of blood pressure and glycosphingolipid deposition. Arterioscler Thromb Vasc Biol 26(4):839\u2013844","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"2774_CR105","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.jacc.2020.12.024","volume":"77","author":"M Pieroni","year":"2021","unstructured":"Pieroni M, Moon JC, Arbustini E, Barriales-Villa R, Camporeale A, Vujkovac AC et al (2021) Cardiac involvement in fabry disease: JACC review topic of the week. J Am Coll Cardiol 77(7):922\u2013936","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"2774_CR106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/CIRCIMAGING.119.009430","volume":"12","author":"S Nordin","year":"2019","unstructured":"Nordin S, Kozor R, Vijapurapu R, Augusto JB, Knott KD, Captur G et al (2019) Myocardial storage, inflammation, and cardiac phenotype in fabry disease after one year of enzyme replacement therapy. Circ Cardiovasc Imaging 12(12):1\u20139","journal-title":"Circ Cardiovasc Imaging"},{"issue":"13","key":"2774_CR107","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1136\/hrt.2008.162800","volume":"95","author":"M Imbriaco","year":"2009","unstructured":"Imbriaco M, Pisani A, Spinelli L, Cuocolo A, Messalli G, Capuano E et al (2009) Effects of enzyme-replacement therapy in patients with Anderson-Fabry disease: a prospective longterm cardiac magnetic resonance imaging study. Heart 95(13):1103\u20131107","journal-title":"Heart"},{"issue":"1","key":"2774_CR108","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11547-011-0710-9","volume":"117","author":"G Messalli","year":"2012","unstructured":"Messalli G, Imbriaco M, Avitabile G, Russo R, Iodice D, Spinelli L et al (2012) Role of cardiac MRI in evaluating patients with Anderson-Fabry disease: assessing cardiac effects of long-term enzyme replacement therapy. Radiol Med 117(1):19\u201328","journal-title":"Radiol Med"},{"issue":"5","key":"2774_CR109","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1161\/CIRCIMAGING.113.000482","volume":"6","author":"RB Thompson","year":"2013","unstructured":"Thompson RB, Chow K, Khan A, Chan A, Shanks M, Paterson I et al (2013) T1 mapping with cardiovascular MRI is highly sensitive for fabry disease independent of hypertrophy and sex. Circ Cardiovasc Imaging 6(5):637\u2013645","journal-title":"Circ Cardiovasc Imaging"},{"issue":"19","key":"2774_CR110","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1136\/heartjnl-2012-302346","volume":"98","author":"DM Sado","year":"2012","unstructured":"Sado DM, Flett AS, Banypersad SM, White SK, Maestrini V, Quarta G et al (2012) Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease. Heart 98(19):1436\u20131441","journal-title":"Heart"},{"issue":"15","key":"2774_CR111","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/j.jacc.2016.07.741","volume":"68","author":"S Nordin","year":"2016","unstructured":"Nordin S, Kozor R, Bulluck H, Castelletti S, Rosmini S, Abdel-Gadir A et al (2016) Cardiac fabry disease with late gadolinium enhancement is a chronic inflammatory cardiomyopathy. J Am Coll Cardiol 68(15):1707\u20131708","journal-title":"J Am Coll Cardiol"},{"issue":"SUPPL 1","key":"2774_CR112","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/jnc.12217","volume":"126","author":"F Weidemann","year":"2013","unstructured":"Weidemann F, St\u00f6rk S, Liu D, Hu K, Herrmann S, Ertl G et al (2013) Cardiomyopathy of Friedreich ataxia. J Neurochem 126(SUPPL 1):88\u201393","journal-title":"J Neurochem"},{"issue":"7","key":"2774_CR113","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/mds.22864","volume":"25","author":"B Rajagopalan","year":"2010","unstructured":"Rajagopalan B, Francis JM, Cooke F, Korlipara LVP, Blamire AM, Schapira AHV et al (2010) Analysis of the factors influencing the cardiac phenotype in Friedreich\u2019s ataxia. Mov Disord 25(7):846\u2013852","journal-title":"Mov Disord"},{"issue":"3","key":"2774_CR114","doi-asserted-by":"publisher","first-page":"e0116396","DOI":"10.1371\/journal.pone.0116396","volume":"10","author":"AH Koeppen","year":"2015","unstructured":"Koeppen AH, Ramirez RL, Becker AB, Bjork ST, Levi S, Santambrogio P et al (2015) The pathogenesis of cardiomyopathy in Friedreich ataxia. PLoS ONE 10(3):e0116396","journal-title":"PLoS ONE"},{"issue":"5254","key":"2774_CR115","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1126\/science.271.5254.1423","volume":"271","author":"V Campuzano","year":"1996","unstructured":"Campuzano V, Montermini L, Molt\u00f2 MD, Pianese L, Coss\u00e9e M, Cavalcanti F et al (1996) Friedreich\u2019s ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science (80-) 271(5254):1423\u20131427","journal-title":"Science (80-)"},{"issue":"2","key":"2774_CR116","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/hmg\/9.2.275","volume":"9","author":"JL Bradley","year":"2000","unstructured":"Bradley JL, Blake JC, Chamberlain S, Thomas PK, Cooper JM, Schapira AHV (2000) Clinical, biochemical and molecular genetic correlations in Friedreich\u2019s ataxia. Hum Mol Genet 9(2):275\u2013282","journal-title":"Hum Mol Genet"},{"issue":"4","key":"2774_CR117","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1080\/14734220600913246","volume":"5","author":"S Michael","year":"2006","unstructured":"Michael S, Petrocine SV, Qian J, Lamarche JB, Knutson MD, Garrick MD et al (2006) Iron and iron-responsive proteins in the cardiomyopathy of Friedreich\u2019s ataxia. Cerebellum 5(4):257\u2013267","journal-title":"Cerebellum"},{"issue":"1","key":"2774_CR118","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3233\/JND-180373","volume":"7","author":"S Mavrogeni","year":"2020","unstructured":"Mavrogeni S, Giannakopoulou A, Katsalouli M, Pons RM, Papavasiliou A, Kolovou G et al (2020) Friedreich\u2019s Ataxia: case series and the additive value of cardiovascular magnetic resonance. J Neuromuscul Dis 7(1):61\u201367","journal-title":"J Neuromuscul Dis"},{"issue":"4","key":"2774_CR119","doi-asserted-by":"publisher","first-page":"305","DOI":"10.14503\/THIJ-14-4198","volume":"43","author":"N Mehta","year":"2016","unstructured":"Mehta N, Chacko P, Jin J, Tran T, Prior TW, He X et al (2016) Serum versus imaging biomarkers in Friedreich ataxia to indicate left ventricular remodeling and outcomes. Texas Hear Inst J 43(4):305\u2013310","journal-title":"Texas Hear Inst J"},{"issue":"2","key":"2774_CR120","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.hfc.2017.12.005","volume":"14","author":"G Calcagni","year":"2018","unstructured":"Calcagni G, Adorisio R, Martinelli S, Grutter G, Baban A, Versacci P et al (2018) Clinical presentation and natural history of hypertrophic cardiomyopathy in RASopathies. Heart Fail Clin 14(2):225\u2013235","journal-title":"Heart Fail Clin"},{"issue":"4","key":"2774_CR121","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.amjcard.2007.03.093","volume":"100","author":"G Limongelli","year":"2007","unstructured":"Limongelli G, Pacileo G, Marino B, Digilio MC, Sarkozy A, Elliott P et al (2007) Prevalence and clinical significance of cardiovascular abnormalities in patients with the LEOPARD syndrome. Am J Cardiol 100(4):736\u2013741","journal-title":"Am J Cardiol"},{"issue":"24","key":"2774_CR122","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1093\/eurheartj\/ehs275","volume":"33","author":"MGD Bates","year":"2012","unstructured":"Bates MGD, Bourke JP, Giordano C, D\u2019Amati G, Turnbull DM, Taylor RW (2012) Cardiac involvement in mitochondrial DNA disease: clinical spectrum, diagnosis, and management. Eur Heart J 33(24):3023\u20133033","journal-title":"Eur Heart J"},{"issue":"1","key":"2774_CR123","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10741-015-9524-5","volume":"21","author":"YHR Hsu","year":"2016","unstructured":"Hsu YHR, Yogasundaram H, Parajuli N, Valtuille L, Sergi C, Oudit GY (2016) MELAS syndrome and cardiomyopathy: linking mitochondrial function to heart failure pathogenesis. Heart Fail Rev 21(1):103\u2013116","journal-title":"Heart Fail Rev"},{"key":"2774_CR124","first-page":"385","volume":"40","author":"DE Meyers","year":"2013","unstructured":"Meyers DE, Basha HI, Koenig MK (2013) Mitochondrial cardiomyopathy: pathophysiology, diagnosis, and management. Texas Heart Inst J 40:385","journal-title":"Texas Heart Inst J"},{"issue":"1","key":"2774_CR125","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12968-015-0145-x","volume":"17","author":"A Florian","year":"2015","unstructured":"Florian A, Ludwig A, Stubbe-Dr\u00e4ger B, Boentert M, Young P, Waltenberger J et al (2015) Characteristic cardiac phenotypes are detected by cardiovascular magnetic resonance in patients with different clinical phenotypes and genotypes of mitochondrial myopathy. J Cardiovasc Magn Reson 17(1):1\u201311","journal-title":"J Cardiovasc Magn Reson"},{"issue":"22","key":"2774_CR126","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","volume":"73","author":"FL Ruberg","year":"2019","unstructured":"Ruberg FL, Grogan M, Hanna M, Kelly JW, Maurer MS (2019) Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol 73(22):2872\u20132891","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"2774_CR127","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1016\/j.jacc.2015.09.075","volume":"66","author":"MA Gertz","year":"2015","unstructured":"Gertz MA, Benson MD, Dyck PJ, Grogan M, Coelho T, Cruz M et al (2015) Diagnosis, prognosis, and therapy of transthyretin amyloidosis. J Am Coll Cardiol 66(21):2451\u20132466","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"2774_CR128","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.jacc.2016.06.053","volume":"68","author":"RH Falk","year":"2016","unstructured":"Falk RH, Alexander KM, Liao R, Dorbala S (2016) AL (Light-Chain) cardiac amyloidosis: a review of diagnosis and therapy. J Am Coll Cardiol 68(12):1323\u20131341","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"2774_CR129","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1016\/j.jacc.2018.03.536","volume":"71","author":"T Kotecha","year":"2018","unstructured":"Kotecha T, Martinez-Naharro A, Treibel TA, Francis R, Nordin S, Abdel-Gadir A et al (2018) Myocardial edema and prognosis in amyloidosis. J Am Coll Cardiol 71(25):2919\u20132931","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"2774_CR130","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jcmg.2013.10.008","volume":"7","author":"M Fontana","year":"2014","unstructured":"Fontana M, Banypersad SM, Treibel TA, Maestrini V, Sado DM, White SK et al (2014) Native T1 mapping in transthyretin amyloidosis. JACC Cardiovasc Imaging 7(2):157\u2013165","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3","key":"2774_CR131","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1161\/CIRCIMAGING.112.973438","volume":"5","author":"LFHJ Robbers","year":"2012","unstructured":"Robbers LFHJ, Baars EN, Brouwer WP, Beek AM, Hofman MBM, Niessen HWM et al (2012) T1 mapping shows increased extracellular matrix size in the myocardium due to amyloid depositions. Circ Cardiovasc Imaging 5(3):423\u2013426","journal-title":"Circ Cardiovasc Imaging"},{"issue":"6","key":"2774_CR132","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.jcmg.2020.03.010","volume":"13","author":"JA Pan","year":"2020","unstructured":"Pan JA, Kerwin MJ, Salerno M (2020) Native T1 mapping, extracellular volume mapping, and late gadolinium enhancement in cardiac amyloidosis: a meta-analysis. JACC Cardiovasc Imaging 13(6):1299\u20131310","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"2774_CR133","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jcmg.2013.08.015","volume":"7","author":"JN Dungu","year":"2014","unstructured":"Dungu JN, Valencia O, Pinney JH, Gibbs SDJ, Rowczenio D, Gilbertson JA et al (2014) CMR-based differentiation of AL and ATTR cardiac amyloidosis. JACC Cardiovasc Imaging 7(2):133\u2013142","journal-title":"JACC Cardiovasc Imaging"},{"issue":"16","key":"2774_CR134","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1161\/CIRCULATIONAHA.115.016567","volume":"132","author":"M Fontana","year":"2015","unstructured":"Fontana M, Pica S, Reant P, Abdel-Gadir A, Treibel TA, Banypersad SM et al (2015) Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 132(16):1570\u20131579","journal-title":"Circulation"},{"issue":"4","key":"2774_CR135","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00392-020-01771-1","volume":"110","author":"G Chatzantonis","year":"2021","unstructured":"Chatzantonis G, Bietenbeck M, Elsanhoury A, Tsch\u00f6pe C, Pieske B, Tauscher G et al (2021) Diagnostic value of cardiovascular magnetic resonance in comparison to endomyocardial biopsy in cardiac amyloidosis: a multi-centre study. Clin Res Cardiol 110(4):555\u2013568","journal-title":"Clin Res Cardiol"},{"key":"2774_CR136","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1161\/CIRCHEARTFAILURE.120.007405","volume":"13","author":"E Ammirati","year":"2020","unstructured":"Ammirati E, Frigerio M, Adler ED, Basso C, Birnie DH, Brambatti M et al (2020) Management of acute myocarditis and chronic inflammatory cardiomyopathy: an expert consensus document. Circ Heart Fail 13:663\u2013687","journal-title":"Circ Heart Fail"},{"key":"2774_CR137","doi-asserted-by":"publisher","first-page":"E69","DOI":"10.1161\/CIR.0000000000000745","volume":"141","author":"RD Kociol","year":"2020","unstructured":"Kociol RD, Cooper LT, Fang JC, Moslehi JJ, Pang PS, Sabe MA et al (2020) Recognition and initial management of fulminant myocarditis: a scientific statement from the American Heart Association. Circulation 141:E69-92","journal-title":"Circulation"},{"issue":"24","key":"2774_CR138","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1016\/j.jacc.2018.09.072","volume":"72","author":"VM Ferreira","year":"2018","unstructured":"Ferreira VM, Schulz-Menger J, Holmvang G, Kramer CM, Carbone I, Sechtem U et al (2018) Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J Am Coll Cardiol 72(24):3158\u20133176","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"2774_CR139","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1161\/01.CIR.94.6.1334","volume":"94","author":"HP Brunner-La Rocca","year":"1996","unstructured":"Brunner-La Rocca HP, S\u00fctsch G, Schneider J, Follath F, Kiowski W (1996) Natural course of moderate cardiac allograft rejection (Internal Society for Heart Transplantation Grade 2) early and late after transplantation. Circulation 94(6):1334\u20131338","journal-title":"Circulation"},{"issue":"8P2","key":"2774_CR140","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1016\/j.jcmg.2019.01.026","volume":"12","author":"RS Dolan","year":"2019","unstructured":"Dolan RS, Rahsepar AA, Blaisdell J, Suwa K, Ghafourian K, Wilcox JE et al (2019) Multiparametric cardiac magnetic resonance imaging can detect acute cardiac allograft rejection after heart transplantation. JACC Cardiovasc Imaging 12(8P2):1632\u20131641","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"2774_CR141","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/S0735-1097(87)80235-8","volume":"9","author":"A Herskowitz","year":"1987","unstructured":"Herskowitz A, Soule LM, David Mellits E, Traill TA, Achuff SC, Reitz BA et al (1987) Histologic predictors of acute cardiac rejection in human endomyocardial biopsies: a multivariate analysis. J Am Coll Cardiol 9(4):802\u2013810","journal-title":"J Am Coll Cardiol"},{"issue":"82","key":"2774_CR142","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1016\/j.jcmg.2018.10.027","volume":"12","author":"M Imran","year":"2019","unstructured":"Imran M, Wang L, McCrohon J, Yu C, Holloway C, Otton J et al (2019) Native T1 mapping in the diagnosis of cardiac allograft rejection: a prospective histologically validated study. JACC Cardiovasc Imaging 12(82):1618\u20131628","journal-title":"JACC Cardiovasc Imaging"},{"issue":"25","key":"2774_CR143","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1161\/CIRCULATIONAHA.121.057006","volume":"145","author":"C Anthony","year":"2022","unstructured":"Anthony C, Imran M, Pouliopoulos J, Emmanuel S, Iliff J, Liu Z et al (2022) Cardiovascular magnetic resonance for rejection surveillance after cardiac transplantation. Circulation 145(25):1811\u20131824","journal-title":"Circulation"}],"container-title":["The International Journal of Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-022-02774-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10554-022-02774-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-022-02774-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T07:18:13Z","timestamp":1681715893000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10554-022-02774-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,21]]},"references-count":143,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["2774"],"URL":"https:\/\/doi.org\/10.1007\/s10554-022-02774-x","relation":{},"ISSN":["1875-8312"],"issn-type":[{"value":"1875-8312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,21]]},"assertion":[{"value":"5 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}